Training activity information
Details
Interpret and problem solve EQA for a range of assays involved in assessing potential plasma cell dyscrasia including an example of investigating concerns with EQA performance
Type
Developmental training activity (DTA)
Evidence requirements
Evidence the activity has been undertaken by the trainee.
Reflection on the activity at one or more time points after the event including learning from the activity and/or areas of the trainees practice for development.
An action plan to implement learning and/or to address skills or knowledge gaps identified.
Considerations
- Investigation concerns
- EQA on assays without EQA schemes
- Limitations of EQA schemes
- Root cause analysis
Reflective practice guidance
The guidance below is provided to support reflection at different time points, providing you with questions to aid you to reflect for this training activity. They are provided for guidance and should not be considered as a mandatory checklist. Trainees should not be expected to provide answers to each of the guidance questions listed.
Before action
- What does effective interpretation of EQA data involve? What are the common assays used in assessing potential plasma cell dyscrasia that are likely to be included in EQA schemes? How are these EQA schemes scored? What is the typical process for investigating and resolving concerns with EQA performance in your laboratory?
- Consider your current understanding and the specific insights you hope to gain in interpreting EQA data and understanding the process of troubleshooting poor performance. What specific aspects related to assays for plasma cell dyscrasia would you like to learn more about? How can you prepare for this DTA?
- Consider possible challenges you might face in interpreting complex EQA data or identifying the root cause of a performance issue.
In action
- When interpreting the EQA results, what parameters are you initially focusing on and why ? If you identify a potential problem, what steps are you taking to investigate the concern with EQA performance? What specific data or processes are you reviewing? What aspects of this EQA interpretation and problem-solving feel well-understood, and where do you need to consciously apply your knowledge of quality assurance principles?
- How effectively are you able to identify potential issues with assay performance based on the EQA data? What specific patterns or results are raising concerns? What challenges are you encountering in pinpointing the root cause of any identified problems or in interpreting complex EQA reports? How does this EQA relate to your understanding of the analytical principles and potential sources of error for these specific assays?
- What support or guidance might you need and where can you get it from?
On action
- What were the key aspects of the EQA data that you reviewed (? If you investigated a concern with EQA performance, what were the specific results or trends that triggered your investigation? What were your initial conclusions about the performance of the assays and the potential cause of any identified issues?
- Did you improve your ability to interpret EQA data for assays related to plasma cell dyscrasia? What specific metrics became clearer? Did you gain a better understanding of the process for investigating and resolving concerns identified through EQA? How did your real-time analysis of the EQA data guide your problem-solving approach? Were there any unexpected findings during your investigation? How does effective participation in EQA contribute to the overall quality assurance and reliability of laboratory testing for plasma cell dyscrasia?
- What areas of EQA interpretation or problem-solving for these assays do you feel you need to develop further and how will you address them? How will you apply the lessons learned from this activity to future EQA reviews and investigations? What resources or guidance ( would be helpful for future reference?
Beyond action
- Since doing this DTA, have you reviewed subsequent EQA reports for these assays? Looking back at your reflections from various DTAs related to quality assurance, have you identified any recurring challenges or areas where your understanding of EQA interpretation has deepened? What further learning or actions will you now consider to enhance your skills in this area?
- Have you discussed EQA results or investigations with senior colleagues or participated in quality management meetings? Did these discussions offer insights into different approaches to EQA interpretation and problem resolution?
- Can you identify instances where the learning from this DTA has informed your review of subsequent EQA reports or contributed to identifying and addressing potential quality concerns in the laboratory? How has this experience contributed to your understanding of the importance of quality assurance and your preparedness for discussions related to laboratory performance?
- What transferable skills did you develop that will be valuable in maintaining and improving the quality of laboratory services in the future? What specific aspects of EQA interpretation and problem-solving for these assays do you feel you need to develop further? What clear actions will you take to pursue this development?
Relevant learning outcomes
| # | Outcome |
|---|---|
| # 1 |
Outcome
Perform laboratory investigations on samples from patients with suspected haematological malignancies. |
| # 2 |
Outcome
Analyse, interpret and report on laboratory investigations for haematological malignancies, including recognition of abnormal results. |
| # 3 |
Outcome
Summarise the limitations of methods used to aid diagnosis of haematological malignancies. |